Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer

Lukas Käsmann, Stefan Janssen, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

AIM: When patients with small cell lung cancer (SCLC) experience locoregional recurrence, surgery is often not employed as salvage therapy. Systemic chemotherapy and radiotherapy are often used. Many radiation oncologists are reluctant to deliver a second course of radiotherapy. However, select patients may benefit from re-irradiation. This study aimed to identify these patients.

PATIENTS AND METHODS: In patients receiving re-irradiation for a locoregional recurrence of SCLC, 11 potential prognostic factors were analyzed for survival.

RESULTS: Survival was positively associated with a Karnofsky performance score ≥80 (p=0.003) and a cumulative dose >90 Gy (p=0.026). A trend was observed for younger age, longer interval between first course of radiotherapy and re-irradiation, a greater dose of re-irradiation and for concurrent chemotherapy.

CONCLUSION: Significant predictors of survival in patients re-irradiated for a locoregional recurrence of SCLC were identified. Patients with a good performance status can benefit from re-irradiation if administered in sufficient doses.

Original languageEnglish (US)
Pages (from-to)803-805
Number of pages3
JournalAnticancer Research
Volume36
Issue number2
StatePublished - Feb 1 2016

Fingerprint

Small Cell Lung Carcinoma
Radiation
Recurrence
Survival
Radiotherapy
Drug Therapy
Salvage Therapy
Re-Irradiation

Keywords

  • Karnofsky performance score
  • re-irradiation
  • recurrence
  • Small cell lung cancer
  • survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer. / Käsmann, Lukas; Janssen, Stefan; Schild, Steven E.; Rades, Dirk.

In: Anticancer Research, Vol. 36, No. 2, 01.02.2016, p. 803-805.

Research output: Contribution to journalArticle

Käsmann, Lukas ; Janssen, Stefan ; Schild, Steven E. ; Rades, Dirk. / Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer. In: Anticancer Research. 2016 ; Vol. 36, No. 2. pp. 803-805.
@article{4bce86f8148946b5af7ac29786a0cd7f,
title = "Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer",
abstract = "AIM: When patients with small cell lung cancer (SCLC) experience locoregional recurrence, surgery is often not employed as salvage therapy. Systemic chemotherapy and radiotherapy are often used. Many radiation oncologists are reluctant to deliver a second course of radiotherapy. However, select patients may benefit from re-irradiation. This study aimed to identify these patients.PATIENTS AND METHODS: In patients receiving re-irradiation for a locoregional recurrence of SCLC, 11 potential prognostic factors were analyzed for survival.RESULTS: Survival was positively associated with a Karnofsky performance score ≥80 (p=0.003) and a cumulative dose >90 Gy (p=0.026). A trend was observed for younger age, longer interval between first course of radiotherapy and re-irradiation, a greater dose of re-irradiation and for concurrent chemotherapy.CONCLUSION: Significant predictors of survival in patients re-irradiated for a locoregional recurrence of SCLC were identified. Patients with a good performance status can benefit from re-irradiation if administered in sufficient doses.",
keywords = "Karnofsky performance score, re-irradiation, recurrence, Small cell lung cancer, survival",
author = "Lukas K{\"a}smann and Stefan Janssen and Schild, {Steven E.} and Dirk Rades",
year = "2016",
month = "2",
day = "1",
language = "English (US)",
volume = "36",
pages = "803--805",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Karnosky Performance Score and Radiation Dose Predict Survival of Patients Re-irradiated for a Locoregional Recurrence of Small Cell Lung Cancer

AU - Käsmann, Lukas

AU - Janssen, Stefan

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2016/2/1

Y1 - 2016/2/1

N2 - AIM: When patients with small cell lung cancer (SCLC) experience locoregional recurrence, surgery is often not employed as salvage therapy. Systemic chemotherapy and radiotherapy are often used. Many radiation oncologists are reluctant to deliver a second course of radiotherapy. However, select patients may benefit from re-irradiation. This study aimed to identify these patients.PATIENTS AND METHODS: In patients receiving re-irradiation for a locoregional recurrence of SCLC, 11 potential prognostic factors were analyzed for survival.RESULTS: Survival was positively associated with a Karnofsky performance score ≥80 (p=0.003) and a cumulative dose >90 Gy (p=0.026). A trend was observed for younger age, longer interval between first course of radiotherapy and re-irradiation, a greater dose of re-irradiation and for concurrent chemotherapy.CONCLUSION: Significant predictors of survival in patients re-irradiated for a locoregional recurrence of SCLC were identified. Patients with a good performance status can benefit from re-irradiation if administered in sufficient doses.

AB - AIM: When patients with small cell lung cancer (SCLC) experience locoregional recurrence, surgery is often not employed as salvage therapy. Systemic chemotherapy and radiotherapy are often used. Many radiation oncologists are reluctant to deliver a second course of radiotherapy. However, select patients may benefit from re-irradiation. This study aimed to identify these patients.PATIENTS AND METHODS: In patients receiving re-irradiation for a locoregional recurrence of SCLC, 11 potential prognostic factors were analyzed for survival.RESULTS: Survival was positively associated with a Karnofsky performance score ≥80 (p=0.003) and a cumulative dose >90 Gy (p=0.026). A trend was observed for younger age, longer interval between first course of radiotherapy and re-irradiation, a greater dose of re-irradiation and for concurrent chemotherapy.CONCLUSION: Significant predictors of survival in patients re-irradiated for a locoregional recurrence of SCLC were identified. Patients with a good performance status can benefit from re-irradiation if administered in sufficient doses.

KW - Karnofsky performance score

KW - re-irradiation

KW - recurrence

KW - Small cell lung cancer

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84979823933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979823933&partnerID=8YFLogxK

M3 - Article

C2 - 26851043

AN - SCOPUS:84979823933

VL - 36

SP - 803

EP - 805

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -